Background The rate of recurrence of giant cell tumor of bone (GCTB) is decreased by use of adjuvant treatments such as phenol, liquid nitrogen, or polymethylmethacrylate (PMMA) during curettage. We assessed recurrence and complication rates and functional outcome after curettage with use of phenol and PMMA, liquid nitrogen and PMMA, and liquid nitrogen and bone grafts. Methods We retrospectively compared the relative effectiveness of treatment of GCTB at two tertiary centers with a regional function from 1990 to 2010. The 132 (of 201) patients who met the inclusion criteria had a mean age of 33 years (range 11-69 years). Treatment assignment depended purely on the center, with primary treatment consisting of curettage with use of phenol and PMMA (n=82) at one center and with use of either liquid nitrogen and PMMA (n=26) or liquid nitrogen and bone grafts (n=24) at the other center. Recurrence and complication rates were determined, and functional outcome was assessed on the basis of the Musculoskeletal Tumor Society (MSTS) score. Results The mean duration of follow-up was 8 years (range 2-22 years). Recurrence rates were comparable among the groups (28% for phenol and PMMA, 31% for liquid nitrogen and PMMA, and 38% for liquid nitrogen and bone grafts; p=0.52). Soft-tissue extension increased the recurrence risk (hazard ratio [HR]=2.1, 95% confidence interval [CI]=1.1-4.0, p=0.024). The complication rate was 33% after use of liquid nitrogen and bone grafts, 27% after liquid nitrogen and PMMA, and 11% after phenol and PMMA (p=0.019); complications included osteoarthritis, infection, postoperative fracture, nonunion, transient nerve palsy, and PMMA leakage. The complication risk was increased by the presence of a pathologic fracture (HR=4.1, 95%CI=1.7-9.5, p=0.001) and use of liquid nitrogen (HR=3.9, 95%CI=1.5-10, p=0.006 for liquid nitrogen and bone grafts; HR=3.1, 95%CI=1.1-8.6, p=0.028 for liquid nitrogen and PMMA). The mean MSTS score was 26 (range 8-30) and was comparable among all three cohorts (p=0.52). Conclusions Recurrence rates were comparable for treatment with phenol and PMMA, liquid nitrogen and PMMA, and liquid nitrogen and bone grafts. Complications rates were higher after use of liquid nitrogen. The functional outcome was excellent in all three cohorts.
Introduction
The main difficulty in management of giant cell tumors of bone (GCTB) is the relatively high recurrence rate after curettage, with most recurrences occurring within the first two postoperative years [1] . Although recurrence rates are lower (0 to 12%) after en bloc resection, curettage with local adjuvants is preferable as it results in less morbidity and superior functional outcome [2] [3] [4] [5] . Without any local adjuvant, reported recurrence rates range from 21% to 65% [6, 7] . The most widely accepted treatment today is curettage combined with phenolization and use of polymethylmethacrylate (PMMA) [7] [8] [9] [10] [11] . Phenol is a chemical agent that induces tumor necrosis and coagulation of proteins at the borders of the cavity [12, 13] . The cytotoxic effect of phenol has been studied in vitro on monolayer cultures of cells from GCTB, and the infiltration-depth has been estimated at 0.2 mm [14] ; the in vivo infiltrationdepth in bone remains unknown [15] . Reported recurrence rates range from 9% to 34% after curettage with phenol [5, 10, 16, 17] and 8% to 27% after curettage with phenol and PMMA [7] [8] [9] [10] [11] ; the additional effect of phenol during curettage with use of PMMA remains unclear [1, 10, 11] . Complications resulting from phenol use include chemical burns, and caution is warranted in vicinity of neurovascular structures and soft tissues [18, 19] . Cryosurgery is used at some centers for aggressive benign bone tumors (e.g. GCTB, aneurysmal bone cyst, chondroblastoma) and low-grade malignant bone tumors (e.g. chondrosarcoma grade I) [20, 21] . Liquid nitrogen induces tissue necrosis by causing the formation of intracellular ice crystals and membrane disruption [22] . Repetitive cycles of rapid freezing and slow thawing increase surgical margins by up to 2 cm, comparable with marginal resection [21, 23] . Use of liquid nitrogen after curettage has been reported to result in recurrence rates of 8% to 42% when used with bone grafts [13, [24] [25] [26] or 0% to 20% when used with PMMA [13, 27, 28] . Complication rates of 12% to 50% have been reported, with the complications including postoperative fracture, skin necrosis, (transient) nerve palsy, and infection [23, 24, 29] . PMMA is a thermal adjuvant that increases surgical margins by up to 1.5 to 2 mm in cancellous and 0.5 mm in cortical bone [30, 31] . When applied after curettage, PMMA has been reported to lower the recurrence risk to 7% to 29%, hypothetically through its hyperthermic reaction [1, 7, 9, 11, [32] [33] [34] [35] . PMMA provides immediate mechanical support and facilitates early radiographic detection of recurrences. Complication rates of 13% to 25% have been reported, with the complications including cement leakage into joints or surrounding soft tissues and osteoarthritic changes. The latter may occur after curettage with PMMA if a large giant cell tumor is close to the articular cartilage [36] [37] [38] [39] . Various combinations of local adjuvants have been used in the past, but the effectiveness of phenol has never been compared with that of liquid nitrogen in a comparative cohort study involving various standard treatments. We therefore assessed recurrences, non-oncological complications, and functional outcome after curettage with use of phenol and PMMA, liquid nitrogen and PMMA, and liquid nitrogen and bone grafts.
Patients and methods
After approval by the local ethics committee, we retrospectively evaluated 201 consecutive patients treated for giant cell tumor of a long bone at two tertiary centers from 1990 to 2010. Sixty-nine patients did not meet the inclusion criteria ( Figure 1) . Sixty of these patients underwent a primary treatment other than the standard treatment because of soft-tissue extension, an intra-articular pathologic fracture, or a difficult anatomic location. (Thirty-two underwent resection, sixteen underwent isolated curettage, eight underwent curettage with use of PMMA, and four underwent curettage with phenol.) Two patients had giant cell tumors at multiple sites. Seven patients were lost to follow-up within two years (4-17 months) after the primary surgery; two of these had had a recurrence (after two and 11 months).
The remaining 132 patients (63 female) were included in the analysis. These patients had a mean follow-up of 93 months (range 24-266 months) and a mean age of 33 years (range 11-69 years). All included patients had a histologically verified GCTB. Two patients developed pulmonary metastases (after 11 and 12 months). Four patients died of a cause unrelated to the tumor after four to nine years; no recurrent or metastatic disease was noted at the time of death. No patients were recalled specifically for this study; all data were obtained from medical records and imaging studies used in the follow-up.
Figure 1
Surgical treatment for giant cell tumor of bone at two tertiary referral centers for orthopaedic oncology with different standard treatment protocols approximating randomization for phenol and liquid nitrogen use, and resulted in three cohorts for this retrospective comparative cohort study. *The primary treatment in forty-three patients was not the typical method described, and six were lost to follow-up. **The primary treatment in 17 patients was not the typical method described, two had giant cell tumors in multiple locations, and one was lost to follow-up. P-PMMA = phenol and PMMA, LN-PMMA = liquid nitrogen and PMMA, LN-BG = liquid nitrogen and bone grafts.
Patients were treated at two tertiary referral centers for musculoskeletal oncology. All surgeons were fellowship-trained orthopaedic oncologists; surgical expertise was comparable at the two centers, and each center specialized in its standard technique. Confounding by indication was minimal as both centers apply similar indications for curettage, with both including patients with a pathologic fracture or soft-tissue extension-primary en bloc resection was rarely considered. Center 1 is situated in a more densely populated area, resulting in a greater number of patients. However, both centers have a regional function, as patients are referred on the basis of their residence, and this minimized the differences between the study populations at the two centers. All patient and tumor characteristics except anatomic location were similar among the three treatment cohorts ( Table 1) . Reconstruction with bone grafts was sometimes preferred in non-weightbearing bones, whereas PMMA was used more often in weight-bearing bones to facilitate immediate weight-bearing. The standard primary treatment at Center 1 consisted of curettage with use of phenol and PMMA (n=82). Three cycles of phenolization of the cavity walls were performed, followed by application of 70% ethanol. Surrounding soft tissues were carefully protected. After treatment, the cavity was rinsed extensively by means of high-speed pulsatile lavage with saline solution. When <10 mm of subchondral bone remained after curettage, bone grafts were used to increase the health of the articular cartilage (n=42). The cavity was filled with PMMA in all 82 patients. One patient also underwent osteosynthesis.
The standard treatment at Center 2 consisted of curettage and highspeed burring followed by cryosurgery involving a liquid nitrogen spray. Thermocouples were used to monitor freezing of the cavity walls [40] , and surrounding soft tissues were continuously irrigated with warm fluids to protect against thermal injury. Three cycles of rapid freezing (to ≤-50 ºC) and slow thawing (to 20 ºC) were performed. In 26 patients, PMMA was used to fill the cavity. As at Center 1, subchondral bone grafts were used when <10 mm of subchondral bone remained (n=17). In 24 patients, the cavity was entirely filled with bone grafts, with no PMMA used. Prophylactic osteosynthesis was used to prevent postoperative fracture in 17 patients treated with liquid nitrogen and PMMA and in eight patients treated with liquid nitrogen and bone grafts. The choices regarding cavity filling with either bone grafts or PMMA and regarding prophylactic osteosynthesis were made intraoperatively and depended on tumor location, cortical stability, and anticipated fracture risk. PMMA was used as often as bone grafts after cryosurgery, and both types of filling material are still used at Center 2. Postoperative treatment after use of phenol and PMMA consisted of functional mobilization with immediate full weight-bearing. Postoperative treatment after use of liquid nitrogen and either bone grafts or PMMA consisted of functional mobilization with partial weight-bearing for at least six weeks. Weight-bearing was increased when radiographs indicated sufficient incorporation and excluded postoperative fracture. High-impact activities were avoided during the first six months, with no subsequent activity restrictions.
Follow-up protocols were similar at the two centers. Potential bias resulting from patient-requested visits between the administratively scheduled regular follow-up appointments would have been similar for both centers and unlikely to influence the outcomes of this study. Follow-up consisted of radiographs at 1.5, 3, 6, 12, 18, and 24 months postoperatively followed by yearly radiographs for the next 10 years. Magnetic resonance (MR) imaging was performed at two and five years postoperatively and if recurrence was suspected. Thoracic computed tomography (CT) scans or chest radiographs were made at presentation and with every proven recurrence to detect pulmonary metastases. Medical records were reviewed to determine age, sex, tumor location, presence of soft-tissue extension, presence of a pathologic fracture, type of surgery and reconstruction, development of local recurrences, development of nononcological complications, functional outcome, and duration of follow-up ( Table 1) . The local recurrences were confirmed by imaging studies and histopathology during the follow-up, and the recurrence rate in each of the three treatment cohorts was confirmed by review of the medical records. Non-oncological complications were recorded and were evaluated in each treatment cohort and according to the use of PMMA or bone grafts for reconstruction. In all patients in whom the location of the tumor was about the knee, preoperative and postoperative radiographs (if available) were reviewed to assess knee osteoarthritis with use of the Kellgren-Lawrence scale [41] . Complete radiographic data were available for 77 (88%) of these 88 patients, and the presence of osteoarthritis of the knee on radiographs was defined as a Kellgren-Lawrence grade 3 or 4 [41] . The functional outcome was evaluated in each treatment cohort and according to the use of PMMA or bone grafts for reconstruction with use of the Musculoskeletal Tumor Society (MSTS) score. Functional results were available for 113 (86%) of the patients at the time of the latest follow-up (mean 8 years [range 2-22 years]); the remaining 19 patients could not be reached.
Statistical analysis
Baseline differences among the cohorts were assessed with use of chi-square and Mann-Whitney U tests. Recurrence-free survival was assessed with use of Kaplan-Meier survival analysis and compared among cohorts with use of log-rank tests. Univariate and multivariate Cox regression analyses were performed to determine risk factors for recurrence and complications. MSTS scores were compared with use of Mann-Whitney U tests.
Results
The recurrence rate after curettage was 28% (23 of 82) in the patients treated with phenol and PMMA, 31% (8 of 26) in those treated with liquid nitrogen and PMMA, and 38% in those treated with liquid nitrogen and bone grafts ( Figure  2 ). Recurrence-free survival at five years was estimated to be 0.76 after use of phenol and PMMA, 0.69 after use of liquid nitrogen and PMMA, and 0.63 after use of liquid nitrogen and bone grafts (p=0.52). In the 40 patients with recurrence, the median time to recurrence was 20 months (range 4-156 months). Seven recurrences occurred later than three years postoperatively.
Recurrences were confined to bone in 27 patients and had soft-tissue extension in 13. Other complications included osteomyelitis (n = 2) and wound infection (n = 2), which resolved after intravenous antibiotics. One of these patients also underwent PMMA replacement with cancellous bone grafts. Two patients had femoral condyle collapse (after 3 and 35 months); the first had KellgrenLawrence grade 4 osteoarthritis and underwent total knee arthroplasty, and the second was not treated because of palliative care for a comorbidity. One patient had a postoperative fracture that healed after PMMA replacement. Nonunion occurred in two patients; both underwent PMMA replacement with cancellous bone grafts, with reduction of the fracture with external fixator in one of the patients. Transient peroneal nerve palsy occurred in one patient. One patient had intra-articular leakage of PMMA; the PMMA that leaked was surgically removed two weeks after the initial surgery. Functional outcome was measured on the basis of the MSTS score at the time of the latest follow-up was comparable among the three cohorts (p=0.52). The mean MSTS score was 26 (range 11-30) in 67 patients treated with phenol and PMMA, 26 (range 8-30) in 22 patients treated with liquid nitrogen and PMMA, NA = not applicable *In both the cohort treated with liquid nitrogen and PMMA and liquid nitrogen and bone grafts, one patient had radiocarpal osteoarthritis; one was treated with wrist arthrodesis. All other patients had osteoarthritis of the knee, which was objectified as Kellgren-Lawrence grade 3 or 4 at final follow-up. **After liquid nitrogen and PMMA, one patient had a postoperative fracture, which was treated with PMMA replacement. After liquid nitrogen and bone grafts, two patients had a femoral condyle collapse; one was treated with total knee arthroplasty and one expectative due to severe co-morbidities.NA = not applicable *In both the cohort treated with liquid nitrogen and PMMA and liquid nitrogen and bone grafts, one patient had radiocarpal osteoarthritis; one was treated with wrist arthrodesis. All other patients had osteoarthritis of the knee, which was objectified as Kellgren-Lawrence grade 3 or 4 at final follow-up. **After liquid nitrogen and PMMA, one patient had a postoperative fracture, which was treated with PMMA replacement. After liquid nitrogen and bone grafts, two patients had a femoral condyle collapse; one was treated with total knee arthroplasty and one expectative due to severe co-morbidities.
and 27 (range 13-30) in 24 patients treated with liquid nitrogen and bone grafts. There was also no clinically relevant difference between the two reconstruction methods with respect to the MSTS score, which averaged 27 (range 13-30) in 24 patients who received bone grafts and 26 (range 8-30) in 89 patients who received PMMA (p=0.039).
Discussion
Most retrospective case series involving treatment of GCTB by curettage followed by use of a local adjuvant have focused on only a single adjuvant.
Comparisons among these series may be misleading as the centers may have had different study populations and different indications for selection of curettage with adjuvants or resection. To our knowledge, the effectiveness of phenol has never been compared directly with that of liquid nitrogen. Recurrence rates did not differ significantly among the three treatment cohorts in the present study, but they were at the higher end of the ranges reported in the literature (Table 4) . These high recurrence rates may be explained by the relatively broad indications for intralesional curettage applied at both centers, including patients with a pathologic fracture or soft-tissue extension. This is in accordance with extended indications for curettage in 80% to 88% of patients as described previously by some authors [7, 9, 10, 42] . In contrast, other authors appear to prefer primary resection (in 32% to 55% of patients) for more complicated cases [1, 5, 6, 12, 43] . At the time of the latest follow-up in the present study, local control had been achieved with use of one or multiple intralesional procedures in 89% of the patients, indicating that repeated curettage with adjuvants is a safe alternative to resection. En bloc resection was rarely considered as the primary treatment at either center, and it was used in only eleven patients with (first or later) recurrences, as expected functional results are inferior [2] [3] [4] [5] . The recurrence rate data indicate that cryosurgery is a good alternative to the more commonly used combination of phenol and PMMA; however, it is preferably performed at centers experienced with this technique, as complications are more common. Whereas bone grafts and PMMA were used equally often at Center 2 for filling of the cavity during the time period described in this study, most giant cell tumors of bone are now treated with curettage and use of liquid nitrogen and PMMA at that center. Rec = recurrence, NR = not reported, U = unknown *Only in later cases PMMA was used instead of bone grafts, but it is not stated in how many patients **In this study only GCT of the sacrum were reported ***In this study only GCT of the small bones of the hand were reported †In this study only the overall recurrence rate was given after curettage with different adjuvants (18%) including phenol, PMMA, liquid nitrogen and combinations thereof. Only for the use of liquid nitrogen, the recurrence rate was further specified (0%).
Non-oncological complications were more common after use of liquid nitrogen and bone grafts (33%) or liquid nitrogen and PMMA (27%) compared with phenol and PMMA (11%). Non-oncological complications were more common after reconstruction with bone grafts (33%) compared with PMMA (mean 15% in two cohorts). However, as the difference in complication rates after cryosurgery (mean 30% in two cohorts) compared with phenolization (11%) was most striking, we conclude that this risk can be attributed to the use of liquid nitrogen and that it is especially elevated in combination with use of bone grafts for reconstruction.
The most common complication in all cohorts was secondary osteoarthritis. It has been hypothesized that a large subchondral bone defect close to the joint in combination with the hyperthermic reaction of PMMA may increase the risk for secondary osteoarthritis [33, [36] [37] [38] [39] . To our knowledge, this is the first study to evaluate the prevalence of osteoarthritis after cancellous bone grafting or PMMA use in the treatment of giant cell tumor of bone about the knee. Osteoarthritis was observed more frequently after cryosurgical treatment, especially if bone grafts were used for reconstruction. In theory, subchondral bone grafts may protect articular cartilage from degeneration by increasing the distance between the cartilage and PMMA, thus creating a barrier against thermal effects [33, 36, 37] . In the present study, subchondral bone grafts were used in patients with little remaining subchondral bone stock (<10 mm), and we only found a modest decrease in the prevalence of osteoarthritis compared with that in patients in whom subchondral bone grafts were not used. However, the numbers available were too small to draw conclusions and we did not study the influence of patient, treatment, and tumor characteristics on osteoarthritis development. A previous detailed analysis of the amount of subchondral bone involvement and the distance between giant cell tumors of bone and articular cartilage demonstrated that these factors both strongly increase the risk for osteoarthritis-thus, in the present study, patients in whom subchondral bone grafts were placed would have been at an a priori increased risk for osteoarthritis [39] . Whereas postoperative fractures were the most important concern after cryosurgery in the past, adequate monitoring of freezing temperatures and prophylactic osteosynthesis in selected cases have decreased fracture rates dramatically (from 25%-50% [21, 29] to 0%-7% [13, 24, 26, 28] ; Table 5 ). The postoperative fracture rate of 6% after cryosurgery in the present study confirms that the fracture risk with current cryosurgery techniques is relatively low.
In the present study, the functional outcome as assessed with the MSTS score was excellent for all adjuvants and reconstruction methods. However, even though joint salvage was achieved in all patients, different cavity fillings and complications might alter the functional outcome. For example, osteoarthritis was more common after cryosurgery, but this did not appear to negatively influence the mean functional outcome. 30 ) after use of liquid nitrogen and bone grafts were reported in a previous study [13] . This study has several strengths: both centers had different but equally accepted standard treatments during the same period, applied identical criteria for the choice between intralesional and wide resection of the giant cell tumor, and had similar surgical expertise. Regional or inter-center differences in treatment have been used previously as instrumental variables [44] .
In observational studies, analysis of instrumental variables can estimate the therapeutic effects of various standard treatments and deal with controlled and uncontrolled confounding [44] [45] [46] . Several assumptions should be met: an instrumental variable should directly affect the treatment decision, must not be related to patient prognosis, and may not affect the primary outcome measures other than through chance [44] [45] [46] . Our study has several limitations. First, it would have been interesting to analyze four cohorts (use of phenol and bone grafts, phenol and PMMA, liquid nitrogen and bone grafts, and liquid nitrogen and PMMA) to compare the unique effects of phenol and liquid nitrogen and the combined effects of these treatments with use or non-use of PMMA. However, as curettage followed by phenolization and bone grafting was performed in only four patients, this cohort was too small to include. In addition, this treatment was abandoned at Center 1 as the surgeons preferred using PMMA because of its advantages. -OSM = osteosynthesis material *4 deep wound infections and 4 superficial wound infections **In this study only giant cell tumors of the sacrum were reported ***Two-stage local excision with liquid nitrogen and PMMA was performed for GCT with intra-articular fracture, first aiming at fracture reduction and union with temporary bone graft and PMMA filling, followed by meticulous re-curettage with liquid nitrogen and PMMA. †In this study only giant cell tumors of the small bones of the hand were reported Second, the decisions for bone grafts, PMMA and osteosynthesis at Center 2 were made intraoperatively and were based on the structural integrity of the remaining bone after curettage. These choices were not standardized and this may have resulted in confounding by indication.
In conclusion, treatment of GCTB remains challenging as recurrence rates remain relatively high after curettage with local adjuvants. Recurrence rates in the present study were comparable for curettage with use of phenol and PMMA, liquid nitrogen and PMMA, and liquid nitrogen and bone grafts. The risk of complications, especially the development of osteoarthritis, was higher with cryosurgery. Functional outcome was excellent in all cohorts, making the relatively high recurrence rates (in comparison with the rate following en bloc resection and endoprosthetic reconstruction) acceptable.
